Article : Inspiring a new era of patient-centric medicines
Article : Small is a Powerful Ingredient for Patient Centric Formulations
Article : Small is Powerful: A Globally Unique Capability for Nanoforming HPAPI’s
In oncology and the wider pharmaceutical market, there is a surge in demand for high- potency active pharmaceutical ingredients (HPAPIs). Dr. David Rowe, Head of Manufacturing and Antonio da Silva, Senior Director Business Operations discuss the globally unique capabilities that Nanoform possess.
Podcast : Empowering a New Era of Patient-Centric Medicines With Nanoform Technologies
Christian Jones Chief Commercial Officer at Nanoform discusses what it truly means to be patient-centric in the modern pharmaceutical industry. Discover the challenges pharma companies are facing as they switch focus, as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.
Article : Embracing GMP Manufacturing to Meet Pharma’s Future
The pharma industry is looking to novel technologies for answers to its challenges in all areas of drug development. Such technologies must be able to adhere to GMP for both clinical and commercial manufacturing. Read this article with DCAT Value Chain Insights to discover how Nanoform can increase your chances of success.
Article: Nanoparticle engineering, Streamlining Drug Development with AI
Elisabetta Micelotta, Science & Technology Team Leader and Jamie Unwin, Commercial Insights Officer discuss the value in applying AI in Pharma and how this can be leveraged to create new and better drugs available faster than would be possible otherwise.
Article: Nanotechnology : A next-generation tool for pulmonary and nasal delivery
Frédérique Bordes-Picard, Vice-President of Business Development looks at the role of nanotechnology is nasal and pulmonary routes of drug delivery and explains how nanoparticle solutions could transform patient comfort and compliance.
Poster: from Nanoformed Powder to 3D printable ink
The flexibility of 3D printing can enable more personalized pharmaceutical products than traditional manufacturing. We embarked on a study to assess the stability of nanoformed piroxicam in 3D printable ink and whether dose control could be achieved. Explore the journey of our piroxicam nanoparticles from nanoformed powder to 3D printable ink in this poster.
11th Annual PODD Recap 2021 Newsletter – Q&A with Edward Hæggström
Our CEO, Prof. Edward Hæggström was featured in the PODD 2021 newsletter where he discussed the exciting developments at Nanoform and the market trends driving the innovation. Edward also delved into the collaborations and partnerships adding value to Nanoform’s nanoparticle engineering technologies.
Nanoparticle Engineering for Patient-Centric Drug Formulation
Nanoparticle Engineering And 3DP Delivery For Game-Changing Oral Therapeutics
In the July 2021 issue of ONDrugDelivery, Niklas Sandler and Thomas West consider the technological advances in nanoparticle engineering that can improve the bioavailability and delivery of oral therapeutics.
Positive results from first-in-human trial of nanoformed piroxicam
Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available non-steroidal anti-inflammatory drug, was nanoformed as a model compound to demonstrate the potential benefits of our CESS(R) nanoforming technology for improving solubility, dissolution and in vivo absorption.
Video: Bio-Europe panel discussion
Our Head of AI, Prof. Jukka Corander joined a panel discussion at BIO-Europe Spring 2021 on “Big data & AI: applications in the real world”. Watch the video to find out out how Sparse Data AI & specifically STARMAP® can transform healthcare.
Nanoparticle Engineering: Revolutionising Oral Drug Delivery ‘White Paper’
Our CTO Niklas Sandler, and Pharmaceutical Development Manager Satu Lakio explain how our nanoparticle engineering technology is revolutionizing oral drug delivery by enhancing solubility and bioavailability.
Avanza Börsdag
Our CEO Edward Hæggström, CFO Albert Hæggström, and CCO Christian Jones present an overview of our nanoforming platform technology at Avanza Börsdag.
Recording of conference call in conjunction with press release
A record of the conference call held to discuss Nanoform’s initiation of the first human trial of a drug candidate nanoformed using our proprietary CESS® technology.
PharmTech
Nanoform scientists outline how our innovative CESS® technology can help overcome the obstacles many drug candidates face when trying to make it through clinical trials.
ONdrugDelivery
Our CTO, Niklas Sandler, and Pharmaceutical Development Manager, Satu Lakio, discuss the advantages of our nanoparticle engineering technology in oral drug development and delivery by boosting solubility and bioavailability.
Business Trends
Our CCO, Christian Jones, discusses the launch our US subsidiary and the extension our partnership with Orion Corporation with Business Trends Magazine.
CHEManager
Nanoform CEO Edward Haeggström and CFO Albert Haeggström discussed the benefits of our cutting-edge nanoforming technology for improving efficiency in Pharma and increasing the rate of drug approval for market with CHEManager.
Nanoform Brochure
In this brochure we share our story, explaining how our unique nanoforming services, including our game-changing CESS® technology, can provide solutions to drug development challenges in Pharma.
Chemicals Knowledge Hub
Our CBO, Dr. Gonçalo Rebelo de Andrade, discusses with Chemicals Knowledge Hub magazine how our nanoforming technology can improve efficiency in the pharmaceutical industry by creating new avenues for drug delivery.
The Small Molecule Manufacturer
Our CCO, Christian Jones, shared his insights with The Medicine Maker into how our nanoforming technology can improve efficiency and create new opportunities for drug development.
Chemistry World
Our CTO, Niklas Sandler, examines the importance of technological innovation for treating age-related diseases in Chemistry World’s Future of Pharma digital supplement.
Chemistry World
Our scientists discuss the advantages of applying a multidisciplinary approach to Pharma innovation in the Chemistry World – Voices in Chemistry digital supplement.
Cleanroom Technology
Our CTO, Niklas Sandler, discusses the growing demand for nanoformed drug particles and the advantages of our proprietary nanoforming technology offers with Cleanroom Technology Magazine.
Technology Networks
Our Head of AI, Jukka Corrander, spoke to Technology Networks about our innovative use of sparse data AI with our proprietary STARMAP™ technology.
BioPharm International
Our CBO, Gonçalo Rebelo de Andrade, discusses the advantages offered by our excipient-free nanoforming technology with BioPharm International.
European Pharmaceutical Manufacturer
Our CTO, Niklas Sandler, explains how our innovative use of nanoforming technology and sparse-data AI is being used to enhance drug molecules in the European Pharmaceutical Manufacturer.